TY - JOUR
T1 - A single dose of lipopolysaccharide into mice with emphysema mimics human Chronic obstructive pulmonary disease exacerbation as assessed by micro-computed tomography
AU - Kobayashi, Satoshi
AU - Fujinawa, Reiko
AU - Ota, Fumi
AU - Kobayashi, Shiho
AU - Angata, Takashi
AU - Ueno, Manabu
AU - Maeno, Toshitaka
AU - Kitazume, Shinobu
AU - Yoshida, Keiichi
AU - Ishii, Takeo
AU - Gao, Congxiao
AU - Ohtsubo, Kazuaki
AU - Yamaguchi, Yoshiki
AU - Betsuyaku, Tomoko
AU - Kida, Kozui
AU - Taniguchi, Naoyuki
PY - 2013/12
Y1 - 2013/12
N2 - Chronic obstructive pulmonary disease (COPD), manifested as emphysema and chronic airway obstruction, can be exacerbated by bacterial and viral infections. Although the frequency of exacerbations increases as the disease progresses, the mechanisms underlying this phenomen on a relargely unknown, and there is a need for a simple in vivo exacerbation model. In this study, we compared four groups of mice treated with PBS alone, elastase alone, LPS alone, and elastase plus LPS. A single intratracheal administration of LPS to mice with elastase-induced emphysema provoked infiltration of inflammatory cells, especiallyCD8+ T cells, in to alveolar spaces and increased matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1, and perforin production in bronchoalveolar lavage fluid at the acute inflammatory phase compared with the other groups. We also measured the percentage of low-attenuation area (LAA%) in the above mice using micro-computed X-ray tomography. The LAA% was the most sensitive parameter forquantitative assessments of emphysema among all the parameters evaluated. Using the parameter of LAA%, we found significantly more severe alveolar destruction in the group treated with elastase plus LPS compared with the other groups during longtermlongitudinalobservations.Webuiltthree-dimensionalimagesof the emphysema and confirmed that the lungs of elastase plus LPS-treated mice contained larger emphysematous areas than mice treated with elastase alone. Although human exacerbation of COPD is clinically and pathologically complicated, this simple mouse model mimics human cases to some extent and willbeuseful for elucidating its mechanism and developing therapeutic strategies.
AB - Chronic obstructive pulmonary disease (COPD), manifested as emphysema and chronic airway obstruction, can be exacerbated by bacterial and viral infections. Although the frequency of exacerbations increases as the disease progresses, the mechanisms underlying this phenomen on a relargely unknown, and there is a need for a simple in vivo exacerbation model. In this study, we compared four groups of mice treated with PBS alone, elastase alone, LPS alone, and elastase plus LPS. A single intratracheal administration of LPS to mice with elastase-induced emphysema provoked infiltration of inflammatory cells, especiallyCD8+ T cells, in to alveolar spaces and increased matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1, and perforin production in bronchoalveolar lavage fluid at the acute inflammatory phase compared with the other groups. We also measured the percentage of low-attenuation area (LAA%) in the above mice using micro-computed X-ray tomography. The LAA% was the most sensitive parameter forquantitative assessments of emphysema among all the parameters evaluated. Using the parameter of LAA%, we found significantly more severe alveolar destruction in the group treated with elastase plus LPS compared with the other groups during longtermlongitudinalobservations.Webuiltthree-dimensionalimagesof the emphysema and confirmed that the lungs of elastase plus LPS-treated mice contained larger emphysematous areas than mice treated with elastase alone. Although human exacerbation of COPD is clinically and pathologically complicated, this simple mouse model mimics human cases to some extent and willbeuseful for elucidating its mechanism and developing therapeutic strategies.
KW - Computed tomography
KW - Elastase
KW - Emphysema
KW - Exacerbation
KW - LPS
UR - http://www.scopus.com/inward/record.url?scp=84890026995&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84890026995&partnerID=8YFLogxK
U2 - 10.1165/rcmb.2013-0074OC
DO - 10.1165/rcmb.2013-0074OC
M3 - Article
C2 - 23822858
AN - SCOPUS:84890026995
SN - 1044-1549
VL - 49
SP - 971
EP - 977
JO - American Journal of Respiratory Cell and Molecular Biology
JF - American Journal of Respiratory Cell and Molecular Biology
IS - 6
ER -